Navigation
-
Research
- Research Overview
- Our Impact
-
Research Activities
- 3-D Tissue Bioprinting
- A Specialized Platform for Innovative Research Exploration (ASPIRE)
- About LitCoin
- Analytical Chemistry
- Assay Development and Screening Technology (ADST)
- Automation
- Bespoke Gene Therapy Consortium (BGTC)
- Biomedical Data Translator
- BrIDGs
- Chemistry Technology
- Clinical Trial Readiness for Rare Diseases, Disorders and Syndromes
-
Clinical and Translational Science Awards (CTSA) Program
-
CTSA Program Applicant Information
- Application Information for PAR-24-272: CTSA Program (UM1 Clinical Trial Optional)
- CTSA Program Application Information: Collaborative & Innovative Acceleration Awards (UG3/UH3 Clinical Trial Optional)
- CTSA Program Application Information: Research Training and Career Development Awards
-
CTSA Program Diversity, Re-training, Re-integration, and Re-entry Supplements
-
CTSA Program Diversity, Re-training, Re-integration, and Re-entry Supplement Awardee Profiles
- Celebrating Wins Both Big and Small
- Decreasing Cancer Disparities by Increasing Patient Understanding
- Discovering Science Yet Driven by the Heart
- Harnessing the Immune System to Help Treat Cancer
- Using Abstract Math to Solve Real-World Crises
- Working to Reduce Cancer Disparities and Fulfilling Childhood Dreams
-
CTSA Program Diversity, Re-training, Re-integration, and Re-entry Supplement Awardee Profiles
- CTSA Program Summary Data Guide
- CTSA Program UM1 Budget Request Tables
- CTSA Program Guidelines
- CTSA Program Projects & Initiatives
- CTSA Program in Action
-
CTSA Program Applicant Information
- Compound Management
- Diagnostic Odyssey
- Extracellular RNA Communication
- Functional Genomics Lab
- Illuminating the Druggable Genome (IDG)
- Informatics
- Matrix Combination Screening
- NIH HEAL
- National Clinical Cohort Collaborative (N3C)
- New Therapeutic Uses
- OpenData Portal
- Platform Vector Gene Therapy (PaVe-GT) Pilot Project
- Rare Diseases Clinical Research Network (RDCRN)
- Rare Diseases Registry Program (RaDaR)
- Somatic Cell Gene Editing
- Stem Cell Translation Laboratory (SCTL)
- Stimulating Peripheral Activity to Relieve Conditions (SPARC)
- Therapeutics for Rare and Neglected Diseases (TRND)
-
Tissue Chip for Drug Screening
- Frequently Asked Questions
- Meet Chip
- Program Collaborations and Partnerships
-
Projects & Initiatives
- Clinical Trials on a Chip
- NASA Biomedical Research and Public Health Collaborations
- Tissue Chip Development
- Tissue Chip Testing Centers
- Tissue Chips for Modeling the Immune System
- Tissue Chips for Studying COVID-19
- Tissue Chips in Space
- Tissue Chips: Disease Modeling and Efficacy
- Tissue Chips: Nociception, Opioid Addiction and Overdose
- Tissue Chip Template Agreements
- Toxicology in the 21st Century (Tox21)
- Research Resources
- Training & Education
- Alliances
- Collaborate With NCATS
- Funding
- Resources For You
- News & Events
- About NCATS